solution by Industry

GMP-Compliant Production Systems for Vaccine Fill-Finish & Biomanufacturing

From vial and ampoule filling lines to bioreactors, cleanrooms, and water systems — integrated vaccine manufacturing infrastructure engineered for global regulatory approval.

Our Product Contact Us

Industry Overview

The Industry at a Glance

The global vaccines market was valued at USD 76.4 billion in 2024 and is expected to grow from USD 78.9 billion in 2025 to USD 145.8 billion by 2034, at a CAGR of 7.1%. Growth is fueled by expanding national immunization programs, pandemic preparedness investments, and the rapid advancement of mRNA, viral vector, and recombinant protein platforms. Geographical expansion in the vaccine industry is driven by global demand for immunization against endemic and pandemic diseases, with manufacturers pursuing entry into emerging markets with large populations and growing healthcare access. This creates significant demand for new GMP-compliant vaccine production facilities — particularly fill-finish capacity and sterile manufacturing infrastructure across Africa, Asia-Pacific, and Latin America.

Product Applications

Where Our Products Are Used

  • 1

    IV Infusion Production Lines

    Complete systems for Non-PVC soft bag, PP bottle, and glass bottle IV solutions, from compounding to filling and sterilization.
  • 2

    Ampoule & Vial Filling Lines

    High-speed aseptic filling and sealing lines for injectable formulations, fully compliant with cGMP requirements.
  • 3

    Oral Solid Dosage (OSD) Plants

    Integrated granulation, tablet pressing, capsule filling, coating, and blister packaging for tablets and capsules.
  • 4

    Pharmaceutical Water Treatment Systems

    Purified water (PW) and water for injection (WFI) generation, storage, and distribution systems meeting pharmacopeia standards.
  • 5

    Cleanroom & HVAC Engineering

    Full facility design including classified cleanrooms, HVAC zoning, and environmental monitoring systems.

technology

Pain Points & Solutions

  • Pain Point: Vaccine fill-finish remains a global bottleneck — limited sterile capacity delays immunization

    Solution: Pre-engineered, validated vial and ampoule filling lines ready for rapid deployment, cutting facility lead-time by months.

  • Pain Point: Coordinating upstream bioprocessing with downstream fill-finish from multiple vendors creates integration gaps.

    Solution: Single-source turnkey delivery — bioreactors, purification, filling lines, cleanroom, and utilities under one integrated project.

  • Pain Point: Meeting WHO prequalification and multi-country GMP standards is complex and time-consuming.

    Solution: All systems designed to simultaneously comply with EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — built for first-pass regulatory success.

Advantages

Why Choose Us

  • 2,500+ production lines delivered in 60+ countries — proven sterile manufacturing expertise

  • 40+ turnkey pharmaceutical factories completed end-to-end

  • Multi-standard GMP compliance (EU, FDA, WHO, PIC/S) engineered into every system

  • 4 self-owned factories for pharma machinery, water treatment, cleanroom, and packaging — full vertical integration

  • Full lifecycle services — consulting, process design, equipment manufacturing, installation, IQ/OQ/PQ validation, tech transfer, and operator training

  • Scalable configurations — from single fill-finish lines to complete vaccine production facilities

case

Success Snapshot

  • National Vaccine Institute

    Southeast Asia

    Delivered a complete vaccine vial filling facility including aseptic filling line, WFI system, Grade A/B cleanroom, and automated packaging. The plant passed WHO prequalification on its first inspection and achieved annual fill-finish capacity of 30 million vaccine doses within 12 months of commissioning.

  • Biopharmaceutical Startup

    North Africa

    Supplied an integrated vaccine production suite with bioreactor systems, downstream purification, vial filling line, and supporting utilities. The project was completed in 18 months, enabling the client to launch local production of two WHO-prequalified vaccines for regional distribution.

testimony

Trusted by Industry Leaders

  • “IVEN delivered our entire fill-finish facility — from water systems and cleanroom to the filling line and packaging. One contract, one responsible partner. We achieved WHO prequalification faster than we thought possible.”

    Dr. N

    Director of Manufacturing

  • “Their ability to integrate bioreactors with downstream fill-finish under one project scope eliminated months of coordination delays. The technology transfer and training were exceptional.”

    Mr. H

    CEO

Support

FAQ

Our systems support vials (liquid and lyophilized), ampoules, pre-filled syringes, and BFS containers across a wide range of vaccine types.

Yes. We provide integrated solutions from bioreactor and fermentation systems through purification, aseptic filling, and final packaging.

All projects are engineered to simultaneously meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP for global market and prequalification readiness.

Most fill-finish projects are delivered in 12–18 months; complete vaccine manufacturing plants in 18–24 months from contract to validated production.

Yes — including preventive maintenance, remote diagnostics, spare parts supply, process optimization, and on-site technical service visits.

Related Industry Solutions

  • End-to-End Pharmaceutical Manufacturing Solutions Built to Global GMP Standards

    From IV infusion lines to oral solid dosage plants — IVEN delivers turnkey pharmaceutical production systems trusted across 70+ countries.

  • Integrated Bioprocessing Systems & Turnkey Biopharmaceutical Factory Solutions

    From bioreactors and aseptic filling lines to cleanroom and water systems — complete GMP-compliant manufacturing infrastructure for biologics producers worldwide.

  • Automated Production Lines for Blood Bags, Collection Tubes & Transfusion Devices

    GMP-compliant, fully integrated manufacturing systems for blood banking consumables — from blood bag making to vacuum tube assembly and collection needle production.

  • Pharmaceutical Water Purification Systems & Cleanroom Engineering Solutions

    GMP-compliant PW, WFI, and clean steam generation systems paired with ISO-classified cleanroom design — the critical utility backbone for every pharma manufacturing facility.

  • Automated Production Lines for Medical Devices & Consumables Manufacturing

    High-speed assembly systems for blood collection tubes, syringes, blood bags, and needles — engineered to international quality standards and delivered turnkey worldwide.

  • End-to-End GMP Manufacturing Solutions for Oncology Drug Production

    From injectable chemotherapy filling lines to oral solid dosage systems and turnkey oncology facilities — purpose-built infrastructure to bring cancer therapies to market faster.

  • Turnkey Injectable & IV Solution Production Lines — From Design to GMP Delivery

    Integrated manufacturing systems built to EU GMP, US FDA cGMP, WHO & PIC/S standards — trusted by pharmaceutical producers in 60+ countries.

  • Complete GMP Production Lines for Oral Solid Dosage Manufacturing

    From granulation and tableting to coating, capsule filling, and packaging — turnkey OSD plant solutions engineered for global regulatory approval.